A crime against humanity not to use invermectin…
1 Like
I believe dr pierre covered that study in his review of the many positive trials. I see English doctors are following the example of their french, American and south African counterparts in trying to overcome the stupidity and obstinacy shown by politicians, @EstebanSexface, @carryharry and @TheBlackSpot
https://twitter.com/MichaelYeadon3/status/1351883048552427520?s=19
1 Like
Come out of the rabbit hole, this guy has form
The fact checkers are in the pocket of Big Pharma
I see and dr pierre?
1 Like
its been “pierre” reviewed
1 Like
My mate’s son made them all take vitamin D - drove them mad about it… they all got covid and he was the only one that got sick.
He was talkin science mate. Another mate of mine told me science was great but you had to be open-minded. That worried me. I didn’t want my brains to fall out.
You’re so much better than this.
1 Like
Thought youd be over on the U.S presidential thread causing havoc
I’d say it’s a massive circle jerk. I’ll step in with the final word at a time of my choosing
3 Likes
It’s over as soon as our leaders want it to be over. Prolonging this nonsense any longer is criminal.
1 Like
Cheap antiparasitic could cut chance of Covid-19 deaths by up to 75%Researchers hail ivermectin findings but say more studies needed on using drug
While the race to find safe and effective vaccines has yielded a number of approved candidates, the quest for effective treatments for Covid-19 has lagged behind © Bloomberg
January 19, 2021 11:05 pm by Donato Paolo Mancini
A cheap, off-patent antiparasitic drug has been shown to have a significant effect in reducing mortality in patients with moderate to severe Covid-19.
Researchers have hailed the preliminary finding as a pivotal step towards broadening the arsenal of drugs used against the disease.
The University of Liverpool’s Andrew Hill and others carried out a meta-analytical breakdown of 18 studies that found that ivermectin was associated with reduced inflammation and a faster elimination of Sars-Cov-2, the virus that causes Covid-19.
if (window !== window.top) { Origami[‘o-ads-embed’].init(); } window.dicnf = {};(function(){/* Copyright The Closure Library Authors. SPDX-License-Identifier: Apache-2.0 */ function aa(a){var b=0;return function(){return be?encodeURIComponent(ab(a,b,c,d,e+1)):"…";return encodeURIComponent(String(a))} function cb(a,b,c){b=b+"//pagead2.googlesyndication.com"+c;var d=db(a)-c.length;if(0>d)return"";a.g.sort(function(n,q){return n-q});c=null;for(var e="",f=0;f=l.length){d-=l.length;b+=l;e=a.i;break}c=null==c?g:c}}a="";null!=c&&(a=e+“trn=”+c);return b+a}function db(a){var b=1,c;for(c in a.h)b=c.length>b?c.length:b;return 3997-b-a.i.length-1};function eb(a,b,c,d,e){if((d?a.g:Math.random())Math.random())}function kb(a){a&&U&&V()&&(U.clearMarks(“goog_”+a.label+""+a.uniqueId+“start"),U.clearMarks("goog”+a.label+""+a.uniqueId+“end"))}jb.prototype.start=function(a,b){if(!this.g)return null;a=new hb(a,b);b="goog”+a.label+""+a.uniqueId+“start";U&&V()&&U.mark(b);return a};function lb(){var a=mb;this.o=nb;this.h=null;this.s=this.l;this.g=void 0===a?null:a;this.i=!1}function ob(a,b,c,d){try{if(a.g&&a.g.g){var e=a.g.start(b.toString(),3);var f=c();var g=a.g;c=e;if(g.g&&“number”===typeof c.value){c.duration=(gb()||fb())-c.value;var k="goog”+c.label+""+c.uniqueId+"_end";U&&V()&&U.mark(k);!g.g||2048=ub&&(sb.g=ub);Y=new lb;Y.h=function(a){var b=G;0!==b&&(a.jc=String(b),b=(b=qa(b))&&b.getAttribute(“data-jc-version”)||“unknown”,a.shv=b)};Y.i=!0;“complete”==W.document.readyState?rb():mb.g&&ka(W,“load”,function(){rb()});G=40;N=function(a,b,c,d){return qb(a,b,c,d)};window.vu=qb(492,function(a){if(B.ebrpfa||sa())a=ia(a,"&cbvp=2");a=a.replace("&","&");Ea(O.h(),a)},void 0,void 0);window.vv=qb(494,function(){var a=O.h();if(!a.h)throw Error(“aiv::err”);a.h()},void 0,void 0);}).call(this);vu(“https://securepubads.g.doubleclick.net/pcs/view?xai\x3dAKAOjssm5Jr6zw173fUDtxhV27PhxctfAZrzDIvt8213H65UDqQxan1NegS5zDW8Oyhy4lZMiJZ-LYd16o8J6kdcMxE0cCpCa262p-CosKNd74UCX4yMNV2M7BpHHdtEv550EXu-DfIYLGnC09-qSNtrUCU8ZtUzpoq66n5cKziyedR6Oh8124slee_Pc_gZeCRjY9woVShdYSWKIxANEujkVf0BmGcvlP18_wLMAUMqXT5rBoQhbd_bnFEbk76tkR8ZT3EtzhdP5xuYGYDYTJoblFz7Exf487HqowkjTwpMF1oKuiNEHBEnt06UEpgoVX27\x26sig\x3dCg0ArKJSzNV96OsgHNTQEAE\x26urlfix\x3d1\x26adurl\x3d”)
(function() { var DEBUG = ‘’.toLowerCase() == ‘true’; var csiStart = (+new Date); var studioObjects = window[‘studioV2’] = window[‘studioV2’] || {}; var publisherSideFilePath = unescape(’’); if(publisherSideFilePath == ‘’) { publisherSideFilePath = ‘/doubleclick/DARTIframe.html’; } else if (publisherSideFilePath.charAt(publisherSideFilePath.length - 1) == ‘/’) { publisherSideFilePath += ‘DARTIframe.html’; } var bookingTimeMetaData = { }; var runtimeMetaData = { }; var exitUrlPatternMacroValues = { }; var macroParser = function (macroName, value) { return (value.indexOf(macroName)
‘].join(’’); document.write(divHtml); adServerData.tag.adContainerElementId = containerId; adServerData.generatedAdSlot = true; } var creatives = studioObjects[‘creatives’] = studioObjects[‘creatives’] || {}; var creative = creatives[creativeKey] = creatives[creativeKey] || {}; var adResponses = creative[‘adResponses’] = creative[‘adResponses’] || []; creative[‘shouldBreakout’] = creative[‘shouldBreakout’] || shouldBreakout; var iframeBusterLibrary = renderingScriptPath + ‘/iframe_buster_’ + versionPrefix + templateVersion + ‘.js’; if(!/^https?:/.test(iframeBusterLibrary)) { iframeBusterLibrary = staticResourceMediaServer + iframeBusterLibrary; } var loadedLibraries = studioObjects[‘loadedLibraries’] = studioObjects[‘loadedLibraries’] || {}; var versionedLibrary = loadedLibraries[templateVersion] = loadedLibraries[templateVersion] || {}; var typedLibrary = versionedLibrary[rendererName] = versionedLibrary[rendererName] || {}; adResponses.push({ creativeDto: creativeDto }); if (shouldBreakout) { if (versionedLibrary[‘breakout’]) { versionedLibrary’breakout’; } else if (!versionedLibrary[‘breakoutLoading’]) { versionedLibrary[‘breakoutLoading’] = true; document.write(’’); } } else if (typedLibrary[‘bootstrap’] && creative[‘creativeDefinition’]) { typedLibrary’bootstrap’; } else { if (!creative[‘definitionLoading’]) { creative[‘definitionLoading’] = true; creativeDto.csiEvents[‘pb’] = (+new Date); document.write(’’); } if (!typedLibrary[‘loading’]) { typedLibrary[‘loading’] = true; creativeDto.csiEvents[‘gb’] = (+new Date); document.write(’’); } } if (isMsnAjaxIframe) { window.setTimeout(“document.close();”, 1000); } })();
{“transport”: {“beacon”: false, “xhrpost”: false},“requests”: {“amp_btr”: “https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsu9S0NRjStWZuEQ2DEVp7Z4g-qKTeEbIGYtj1IAQlT1UC4ZZaabDl77ltL3sBMNCvb4wg4qnn9GK78lZ0tiH0aKwHZd1yi0zt8Gk_e8WvugXwRwOQDYNfdmq05MHlqymfCTM2AciaxURZ5UoRLhah8Zlpbay8exRB57pQCebsiZ72myiiZAPniATKTobML_MNtsRq_MpFuiLAeeeficccI_5lv2VoCYOP3F2VV-tQYRREnyrv1-113unM6s48uB_Y-O1lJMbizlP44ldeOvwjNKAAM7zZg1FMiQ5DFiZL-zDzuyo0LYjmDPY9dD6Gbadd8&sig=Cg0ArKJSzPqoxGVsjNvQEAE&urlfix=1&adurl="},"triggers”: {“b2r_iniLoad”: {“on”: “ini-load”,“request”:“amp_btr”}}}{“transport”: {“beacon”: true, “xhrpost”: false},“requests”: {“ampeos”: “https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjst10hc8lewOEsTH8Y72goTiMQVUWAv6lUvXdy1MRdLsyD9TheTku6lTRd86STupgmLkRFUp65hfipZFi75rPS__nFQT7n5Bmkp8qMNeg-4&sig=Cg0ArKJSzHxj8BwYZPWHEAE&id=ampeos&o=${elementX},${elementY}&d=${elementWidth},${elementHeight}&ss=${screenWidth},${screenHeight}&bs=${viewportWidth},${viewportHeight}&mcvt=${maxContinuousVisibleTime}&mtos=0,0,${maxContinuousVisibleTime},${maxContinuousVisibleTime},${maxContinuousVisibleTime}&tos=0,0,${totalVisibleTime},0,0&tfs=${firstSeenTime}&tls=${lastSeenTime}&g=${minVisiblePercentage}&h=${maxVisiblePercentage}&pt=${pageLoadTime}&tt=${totalTime}&rpt=${navTiming(navigationStart,loadEventStart)}&rst=${navTiming(navigationStart)}&r=de&isd=${initialScrollDepth}&msd=${maxScrollDepth}&avms=ampa"},"triggers”: {“endOfSession”: {“on”: “visible”,“request”: “ampeos”,“visibilitySpec”: {“reportWhen”: “documentExit”,“selector”: “:root”,“visiblePercentageMin”: 50}}}}
{“uid”:0.7065051176897503,“hostPeerName”:“https://amp.ft.com”,“initialGeometry”:"{“windowCoords_t”:0,“windowCoords_r”:360,“windowCoords_b”:657,“windowCoords_l”:0,“frameCoords_t”:1052,“frameCoords_r”:330,“frameCoords_b”:1302,“frameCoords_l”:30,“posCoords_t”:1052,“posCoords_b”:1302,“posCoords_r”:330,“posCoords_l”:30,“styleZIndex”:"",“allowedExpansion_r”:60,“allowedExpansion_b”:407,“allowedExpansion_t”:0,“allowedExpansion_l”:0,“yInView”:0,“xInView”:1}",“permissions”:"{“expandByOverlay”:true,“expandByPush”:true,“readCookie”:false,“writeCookie”:false}",“metadata”:"{“shared”:{“sf_ver”:“1-0-37”,“ck_on”:1,“flash_ver”:“26.0.0”,“canonical_url”:“https://www.ft.com/content/e7cb76fc-da98-4a31-9c1f-926c58349c84",“amp”:{“canonical_url”:“https://www.ft.com/content/e7cb76fc-da98-4a31-9c1f-926c58349c84”}}}",“reportCreativeGeometry”:false,“isDifferentSourceWindow”:false,“sentinel”:“0-23536653571268146171”,“width”:300,“height”:250,"_context":{“ampcontextVersion”:“2101152047000”,“ampcontextFilepath”:“https://3p.ampproject.net/2101152047000/ampcontext-v0.js”,“sourceUrl”:“https://amp.ft.com/content/e7cb76fc-da98-4a31-9c1f-926c58349c84?__twitter_impression=true”,“referrer”:“https://t.co/5ILqgfKIGD?amp=1”,“canonicalUrl”:“https://www.ft.com/content/e7cb76fc-da98-4a31-9c1f-926c58349c84”,“pageViewId”:“2376”,“location”:{“href”:“https://amp.ft.com/content/e7cb76fc-da98-4a31-9c1f-926c58349c84?__twitter_impression=true”},“startTime”:1611239015341,“tagName”:“AMP-AD”,“mode”:{“localDev”:false,“development”:false,“esm”:false,“minified”:true,“lite”:false,“test”:false,“version”:“2101152047000”,“rtvVersion”:“012101152047000”},“canary”:false,“hidden”:false,“initialLayoutRect”:{“left”:30,“top”:1052,“width”:300,“height”:250},“initialIntersection”:{“time”:3232.000000003609,“rootBounds”:{“left”:0,“top”:0,“width”:360,“height”:657,“bottom”:657,“right”:360,“x”:0,“y”:0},“boundingClientRect”:{“left”:30,“top”:1052,“width”:300,“height”:250,“bottom”:1302,“right”:330,“x”:30,“y”:1052},“intersectionRect”:{“left”:0,“top”:0,“width”:0,“height”:0,“bottom”:0,“right”:0,“x”:0,“y”:0},“intersectionRatio”:0},“domFingerprint”:“2363123148”,“experimentToggles”:{“canary”:false,“a4aProfilingRate”:false,“adsense-ad-size-optimization”:false,“amp-accordion-display-locking”:true,“amp-action-macro”:true,“amp-story-responsive-units”:true,“amp-story-v1”:true,“chunked-amp”:true,“doubleclickSraExp”:false,“doubleclickSraReportExcludedBlock”:false,“expand-json-targeting”:true,“fix-inconsistent-responsive-height-selection”:false,“flexAdSlots”:false,“intersect-resources”:false,“ios-fixed-no-transfer”:false,“pump-early-frame”:true,“adsense-ptt-exp”:true,“doubleclick-ptt-exp”:false,“fie-resources”:false,“visibility-trigger-improvements”:true},“sentinel”:“0-23536653571268146171”}}" height=“250” width=“300” title=“3rd party ad content” data-amp-3p-sentinel=“0-23536653571268146171” allow=“sync-xhr ‘none’;” frameborder=“0” allowfullscreen=”" allowtransparency="" scrolling=“no” marginwidth=“0” marginheight=“0” sandbox=“allow-top-navigation-by-user-activation allow-popups-to-escape-sandbox allow-forms allow-modals allow-pointer-lock allow-popups allow-same-origin allow-scripts” class=“i-amphtml-fill-content” id=“google_ads_iframe_1” style=“border: 0px !important; margin: auto; padding: 0px !important; display: block; height: 250px; max-height: 100%; max-width: 100%; min-height: 0px; min-width: 0px; width: 300px; position: absolute; top: 0px; left: 0px; bottom: 0px; right: 0px;”>
In six of these trials, the risk of death was reduced by 75 per cent in a subset of patients with moderate to severe Covid-19.
The only antiviral with some sort of approval globally to treat Covid-19 is Gilead Sciences’ remdesivir, which has shown some benefit in shortening hospital stays but no clear-cut effect on mortality or viral loads, a measure of how much virus circulates in a patient’s blood stream.
Ivermectin is technically not an antiviral, though these results suggest that the drug may enjoy antiviral properties. It is usually used to treat lice and scabies infestations as well as more serious parasites such as river blindness.
Dr Hill said the ivermectin results were encouraging, but further studies were needed to provide global regulators with evidence robust enough to warrant approvals.
“It’s a generic drug used all over the world. It costs 12 cents to make the drug substance. The drug costs $3 in India, $960 in the US,” Dr Hill told the Financial Times.
The drug could make it harder for people to be infected and it could be harder for those with the disease to infect anyone else, the researchers have posited.
“If people testing positive for Covid-19 are treated immediately with a drug which clears the virus quickly, this might make them less infectious,” Dr Hill said. “This ‘treatment as prevention’ strategy works for HIV and should now be tested for Covid-19.”
RecommendedCovid infection shown to provide as much immunity as vaccines
“The purpose of this report is to forewarn people that this is coming: get prepared, get supplies, get ready to approve it,” Dr Hill said. “We need to be ready.”
Ivermectin is not approved in the UK and is usually imported from France. But researchers were adamant that many of the studies that had been looked at had not been peer-reviewed and that meta-analyses, which look at many studies at once, could be prone to errors.
While the race to find safe and effective vaccines has yielded a number of approved candidates and some countries have begun large-scale vaccination campaigns, the quest for effective treatments for Covid-19 has lagged behind. Researchers have mostly focused on preventing hospitalisation and reducing death rates for those who become critically ill and end up in hospital.
“Vaccination is central to the response to the epidemic,” Dr Hill said. “But this might help reduce infection rates by making people less infectious and it might reduce death rates by treating the viral infection.”
Copyright The Financial Times Limited . All rights reserved. Please don’t copy articles from FT.com and redistribute by email or post to the web.
View comments
1 Like
It looks like the city of mexico are part of the conspiracy?
1 Like
Looks like invermectin is going through the scientific process at the moment of trialing and if successful increasing the size and scale. Hopefully it’s a great success
Now? It’s been successfully used for months. How many people do you think were killed by WHO recommended intubation? How many lives would have been saved?
2 Likes
You are on the cusp of a huge huge Internet victory here.
1 Like
lads clinging to terms like ‘peer review’ and ‘clinical trial’ for months, meanwhile a vaccine is developed and distributed …within months.
You have to wonder what is dead within them.
4 Likes